EichorEICHOR
Location: Tauranga Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Tauranga

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Tauranga Hospital · Pfizer · NCT07028853
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0335 · Celgene · NCT05519085
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Tauranga Hospital-Bay of Plenty Clinical Trials Unit ( Site · Merck Sharp & Dohme LLC · NCT06623422
Pan Tumor Rollover Study
Phase 2 · Local Institution - 0269 · Bristol-Myers Squibb · NCT03899155
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Imed Radiology · Pfizer · NCT06629779
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Local Institution - 0407 · Bristol-Myers Squibb · NCT06561386
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · Momentum Tauranga · Uniquity One (UNI) · NCT06496620
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Investigational Site Number: 5540002 · Sanofi · NCT07184931
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Phase 3 · Te Whatu Ora - Hauora a Toi Bay of Plenty · The University of Queensland · NCT04939935
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · Tauranga Hospital-Bay of Plenty Clinical Trials Unit ( Site · Merck Sharp & Dohme LLC · NCT06136624
A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)
NA · Tauranga Urology Research Ltd · Andromeda Surgical · NCT07741656
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Pr
Phase 3 · Tauranga Hospital · Boehringer Ingelheim · NCT06238622
TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children
Phase 3 · Tauranga Hospital · Starship Child Health, Te Toka Tumai Auckland · NCT06259006
Exploring the Health Benefits of Sauna Bathing
NA · The Centre for Health · The Centre for Health · NCT06875466
Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH
NA · Tauranga Urology Research Limited · ProArc Medical · NCT04627701
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Phase 3 · Tauranga Hospital · UMC Utrecht · NCT02735707
Better Evidence and Translation for Calciphylaxis
Phase 3 · Tauranga Hospital · University of Sydney · NCT05018221
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib
Phase 3 · Tauranga Hospital · BeOne Medicines · NCT06742996
Staphylococcus Aureus Network Adaptive Platform Trial
Phase 4 · Tauranga Hospital · University of Melbourne · NCT05137119
A Prospective, Multicenter, Open-label Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP
NA · Tauranga Urology Research Limited · Andromeda Surgical · NCT06668142
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · Research Site · AstraZeneca · NCT06878261
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Ch
Phase 3 · Tauranga Hospital · BeOne Medicines · NCT06973187
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Phase 2 · Bay of Plenty Clinical Trials Unit · Avalyn Pharma Inc. · NCT06951217
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastati
Phase 2/Phase 3 · Tauranga Hospital, Clinical Trials Unit · Hoffmann-La Roche · NCT07413939
Look up another city
Look up another condition